Table 1 Nested R2 results for all individual studies for each gene set

From: The role of polygenic risk score gene-set analysis in the context of the omnigenic model of schizophrenia

Study details

Gene sets

Study ID

Case (N)

Control (N)

TCF4

FMRP

MIR137 (up)

MIR137 (down)

CHD8 (up)

CHD8 (down)

Cancer

Heart disease

clm2

3426

4085

0.00400

0.00132

0.00266

0.00034

0.00046

0.00000

0.00470

0.00130

mgs2

2638

2482

0.00840

0.00741

0.00534

0.00596

0.00469

0.00415

0.00401

0.00515

clo3

2105

1975

0.01693

0.01226

0.01090

0.01455

0.01039

0.04791

0.01627

0.00143

s234

1980

2274

0.00584

0.00232

0.00207

0.00084

0.00258

0.00113

0.00053

0.00179

swe5

1764

2581

0.00636

0.00761

0.00618

0.00397

0.00498

0.00379

0.00333

0.00325

irwt

1291

1006

0.00980

0.01104

0.00764

0.00005

0.00312

0.01148

0.01386

0.00609

gras

1067

1169

0.00820

0.00433

0.00765

0.00230

0.00407

0.00965

0.00044

0.00246

swe6

975

1145

0.00970

0.00366

0.02518

0.00414

0.00202

0.00305

0.00175

0.00221

ajsz

894

1594

0.00434

0.00592

0.00172

0.00850

0.00249

0.00154

0.00227

0.00001

aber

719

697

0.00623

0.00832

0.00314

0.00093

0.00171

0.01189

0.00026

0.00070

ucla

700

607

0.00835

0.00573

0.00251

0.00266

0.00005

0.00174

0.00007

0.00327

uktr

649

649

0.00911

0.00047

0.03779

0.03675

0.00208

0.00358

0.00690

0.00031

pewb

574

1812

0.00603

0.00211

0.00317

0.00158

0.00100

0.00565

0.00686

0.00108

cou3

530

678

0.00725

0.00817

0.01952

0.00010

0.00551

0.00599

0.00131

0.00455

lemu

516

516

0.00011

0.00023

0.00017

0.00935

0.00013

0.00001

0.00182

0.00425

uclo

509

485

0.00528

0.01287

0.00618

0.01092

0.00459

0.00105

0.00000

0.00158

lie5

497

389

0.00912

0.00144

0.00028

0.00018

0.00125

0.00495

0.00101

0.00638

denm

471

456

0.00068

0.01327

0.00062

0.00025

0.00001

0.00010

0.00220

0.00312

asrb

456

287

0.00402

0.00187

0.00745

0.00503

0.00061

0.00010

0.00183

0.00249

munc

421

312

0.00558

0.01080

0.00006

0.00737

0.00234

0.00158

0.00397

0.00134

cati

397

203

0.01392

0.01451

0.02506

0.00855

0.00108

0.02120

0.00005

0.00137

caws

396

284

0.00268

0.00539

0.00722

0.00231

0.00011

0.00994

0.00153

0.00613

top8

377

403

0.00772

0.01392

0.00601

0.00016

0.00024

0.00394

0.00003

0.00363

edin

367

284

0.00528

0.04107

0.00202

0.01422

0.00085

0.01435

0.00378

0.00280

port

346

215

0.00016

0.00135

0.00185

0.00487

0.00000

0.00586

0.00038

0.00021

umeb

341

577

0.00684

0.00864

0.00409

0.01769

0.00659

0.00752

0.00195

0.00122

msaf

325

139

0.00026

0.00064

0.00169

0.00080

0.00009

0.00335

0.00158

0.00009

ersw

265

319

0.00635

0.00846

0.00327

0.00351

0.00085

0.00003

0.00015

0.00675

dubl

264

839

0.00921

0.00025

0.00434

0.00224

0.00141

0.01166

0.02123

0.00845

egcu

234

1152

0.00291

0.00213

0.00041

0.00047

0.00449

0.00037

0.00520

0.00027

swe1

215

210

0.00133

0.00027

0.00237

0.00326

0.00221

0.03613

0.00243

0.01048

buls

195

608

0.00579

0.00950

0.01389

0.00028

0.00979

0.00280

0.00821

0.00119

umes

193

704

0.01759

0.00096

0.00041

0.00078

0.00084

0.00155

0.00026

0.00156

zhh1

190

190

0.00023

0.00111

0.01705

0.00005

0.00063

0.00041

0.00031

0.00195

lacw

157

245

0.02095

0.02732

0.00884

0.01177

0.02024

0.01505

0.00536

0.00354

pews

150

236

0.00076

0.00004

0.00038

0.01161

0.00008

0.00192

0.00126

0.00095

lie2

133

269

0.00948

0.00167

0.01504

0.00286

0.01548

0.00407

0.00096

0.00015

butr

70

70

0.00577

0.00397

0.00210

0.00075

0.00495

0.00218

0.00251

0.00005

cims

67

65

0.00005

0.00006

0.00602

0.00830

0.02008

0.00455

0.00226

0.00164

  1. Table of results in each individual study; the first column indicates the PGC2 label used for each study. The table is sorted by the number of cases. Highlighted boxes had a level of significance p < 0.05. Further details for each study and their respective size can also be found in the supplement and the original PGC2 study [1]